論文 2024.03.05
Modeling clade I mpox lesion transition dynamics - A retrospective analysis of clinical data in DRC - Shingo Iwami, U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) International Conference on Emerging Infectious Diseases (EID) in the Pacific Rim
論文 2024.02.27
Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults. E.Morino et al.,NEIJM Evid, Vol.3, No.3,EVIDoa2300290 (2024)
論文 2024.02.20
Topological Flow Data Analysis (TFDA): theory and applications Takashi Sakajo, Coloquium at Indian Instritute of Technology, Hyderabad
論文 2024.02.18
FOXO1 stimulates tip cel- enriched gene expression in endothelial cels. Y. Miyamura et al.,iScience, Vol.27, No.3, p.10916(2024)
論文 2024.02.16
Staged therapeutic surgery for progressive pulmonary regurgitation and pacemaker induced cardiomyopathy after the tetralogy of falot repair. G. Inno et al., Journal of cardiothoracic surgery, Vol.19, No.1, p.98(2024)
論文 2024.02.16
Toward the integration of speciation research Stankowski, S.et al.,Evolutionary Journal of the Linnean Society, Vol.3, No.1(2024)
論文 2024.02.14
Virological characteristics of the SARS-CoV-2 BA.2.86 variant. T.Tamura et al.,Cel Host Microbe, Vol.32, No.2, pp.170-180(2024)
論文 2024.02.13
The Development of a Rapid, High-Throughput Neutralization Assay Using a SARS-CoV-2 Reporter. R. Suzuki et al.,J Virol Methods, Vol.326, p114894(2024)
論文 2024.02.08
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant. T. Tamura et al.Nat Commun, Vol.15, No.1, p.1176(2024)
論文 2024.01.21
The Eco-Evolutionary Dynamics of Batesian Mimicry H.Tomizuka et al.,Journal of Theoretical Biology, Vol.577,p.111683(2024)
論文 2024.01.17
Structural basis of hepatitis B virus receptor binding. J.Asami et al.,Nat Struct Mol Biol,Vol.31,No.3,pp.447-454(2024)
講演 2024.01.07
Topological Flow Data Analysis for Blood Flows inside a Heart Takashi Sakajo, GEOTOP-A International Conference -- Applications of Geometry and Topology
論文 2023.12.25
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection S.Miyamoto et al.,Proceedings of the National Academy of Sciences of the United States of America, Vol.120, No.52,2314808120(2023)
論文 2023.12.25
Significant response of patients with transformed folicular lymphoma with rapid disease progression to CAR- T therapy T.Hirano et al., J Clin Exp Hematop, Vol.63, No.4, pp.266-269(2023)
論文 2023.12.20
Association of Clostridium butyricum therapy using the live bacterial product CBM588 with the survival of patients with lung cancer receiving chemoimmunotherapy combination Y.Tomita et al.,Cancer, Vol.16, No.1, p47(2023)
論文 2023.12.17
Conversion of raltegravir carrying a 1,3,4-oxadiazole ring to a hydrolysis product upon pH changes decreases its antiviral activity T.Nakamura et al.,PNAS Nexus., Vol.3, No.1, pgad446(2023)
論文 2023.12.17
Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history T.Nishiyama et al.,Vaccine, Vol.41, p.7655(2023)
講演 2023.12.17
The phoenix hypothesis of speciation: reproductive isolation among populations experiencing extinction risk Ryo Yamaguchi, The 3rd AsiaEvo Conference
論文 2023.12.14
Assessing the effects of antiretroviral therapy-latency- reversing agent combination therapy on eradicating replication-competent HIV provirus in a Jurkat cel culture model K.Matsuda et al.,STAR Protocol, Vol.4, No.4,p.102547(2023)
講演 2023.12.14
異分野融合アプローチを駆使した創薬DX研究 岩見真吾,第97回 日本薬理学会年会